Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
27.7 /100
Rank 110 out of 131 Industries -
Advance/Decline
14/8
-
No. of Companies22
-
Avg. Market Cap4,734
-
Price to Earning Ratio36.75
-
Price to Earning Growth Ratio0.68
-
Price to Book Ratio14.65
-
Return on Equity34.72
-
Return on Capital Employed-
-
Return on Assets17.15
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %-584.29 %
-
Net Profit Growth Qtr YoY %-204.35 %
-
Net Profit Growth Qtr QoQ %-5.37 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc |
|
382.2
|
20.7
|
L
 5.2%
H
19.8
20.8
|
L
 9.6%
H
18.8
20.8
|
L
 13.4%
H
17.4
20.8
|
L
 19.8%
H
16.6
21
|
L
 -32.9%
H
16.6
38.3
|
L
 -66.2%
H
16.6
69.6
|
L
 -79.6%
H
16.6
104.0
|
L
 -62.7%
H
16.6
138.0
|
| Argen X SE (ADR) |
|
55,171.7
|
887.2
|
L
 -0.2%
H
880.7
907.4
|
L
 1.1%
H
837.7
934.0
|
L
 9.7%
H
793.2
934.0
|
L
 28.1%
H
690.9
934.0
|
L
 58.4%
H
510.1
934.6
|
L
 128.8%
H
327.7
934.6
|
L
 182.8%
H
249.5
934.6
|
L
H
17.3
934.6
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
0.3
|
L
 -3.9%
H
0.3
0.3
|
L
 -21.9%
H
0.3
0.3
|
L
 -47.9%
H
0.3
0.5
|
L
 -58.3%
H
0.3
1.1
|
L
 -89.9%
H
0.3
3.5
|
L
 -82.3%
H
0.3
6.2
|
L
 -99.1%
H
0.3
99
|
L
 -99.4%
H
0.3
620
|
| Niagen Bioscience Inc |
|
272.4
|
3.4
|
L
 3.3%
H
3.3
3.4
|
L
 -2.3%
H
3.3
3.6
|
L
 -11.4%
H
3.3
4.0
|
L
 -23.5%
H
3.3
5.1
|
L
 -75.3%
H
3.3
14.7
|
L
 116.5%
H
1.3
14.7
|
L
 -62.7%
H
1.2
14.7
|
L
 18.3%
H
1.2
23.7
|
| Cronos Grp Inc |
|
1,050.0
|
2.8
|
L
 2.9%
H
2.7
2.8
|
L
 3.7%
H
2.6
2.8
|
L
 2.9%
H
2.6
2.9
|
L
 11.5%
H
2.4
3.3
|
L
 47.1%
H
1.9
3.4
|
L
 51.1%
H
1.6
3.4
|
L
 -68.4%
H
1.6
9.1
|
L
H
0.2
25.1
|
| Enveric Biosciences Inc |
|
5.7
|
1.4
|
L
 10.9%
H
1.3
1.5
|
L
 10.9%
H
1.3
1.5
|
L
 -36.3%
H
1.3
2.4
|
L
 -23.7%
H
1.3
7.9
|
L
 -90.7%
H
1.3
17.6
|
L
 -99.8%
H
1.3
701.6
|
L
 -100.0%
H
1.3
33660
|
L
 -100.0%
H
1.3
12150000
|
| ZeroStack Corp |
|
8.3
|
3.4
|
L
 -3.4%
H
3.3
3.8
|
L
 -15.1%
H
3.3
4.3
|
L
 -23.1%
H
3.3
5.2
|
L
 -47.3%
H
3.3
7.8
|
L
 -86.0%
H
3.3
47
|
L
 -96.9%
H
3.3
213.7
|
L
 -99.9%
H
3.3
16731
|
L
H
3.3
16731
|
| IM Cannabis Corp |
|
1.3
|
0.1
|
L
H
0.1
0.2
|
L
 -22.2%
H
0.1
0.2
|
L
 -50%
H
0.1
0.4
|
L
 -72%
H
0.1
0.6
|
L
 -95.0%
H
0.1
3.8
|
L
 -97.5%
H
0.1
8.1
|
L
 -100.0%
H
0.1
328.8
|
L
H
0.1
697.8
|
| Lifevantage Corp |
|
83.5
|
6.6
|
L
 -0.5%
H
6.4
7
|
L
 3.3%
H
5.8
7
|
L
 -4.5%
H
5.5
11.7
|
L
 54.3%
H
3.9
11.7
|
L
 -48.4%
H
3.9
15
|
L
 58.4%
H
3.9
27.4
|
L
 -4.5%
H
3.0
27.4
|
L
 -49.8%
H
2.9
27.4
|
| Mannatech Inc |
|
9.8
|
5.1
|
L
 0.8%
H
5
5.2
|
L
 -6.5%
H
5
5.8
|
L
 -8.3%
H
5
6.1
|
L
 -27.1%
H
3.8
8.5
|
L
 -46.4%
H
3.8
12.5
|
L
 -60.4%
H
3.8
16.5
|
L
 -80.5%
H
3.8
49.1
|
L
 -75.2%
H
3.8
49.1
|
| Natural Alternatives Intl Inc |
|
15.0
|
2.4
|
L
 -1.2%
H
2.4
2.5
|
L
 -10.5%
H
2.4
2.7
|
L
 -6.3%
H
2.4
2.8
|
L
 -12.5%
H
2.4
2.9
|
L
 -30.9%
H
2.3
5.0
|
L
 -68.2%
H
2.3
7.6
|
L
 -82.0%
H
2.3
19.9
|
L
 -77.7%
H
2.3
19.9
|
| Nature`s Sunshine Products Inc |
|
369.6
|
21.0
|
L
 1.7%
H
20.7
21.5
|
L
 4.5%
H
19.9
21.5
|
L
 -4.0%
H
19.4
22.5
|
L
 -11.1%
H
19.4
28
|
L
 47.3%
H
13.0
28.1
|
L
 55.0%
H
10.8
28.1
|
L
 16.1%
H
7.9
28.1
|
L
 107.3%
H
5.5
28.1
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
0.0
|
0.1
|
L
 -12.5%
H
0.1
0.1
|
L
 -53.3%
H
0.1
0.2
|
L
 -93.8%
H
0.1
26.7
|
L
 -97.7%
H
0.1
26.7
|
L
 -100.0%
H
0.1
1488
|
L
 -100.0%
H
0.1
5808
|
L
 -100.0%
H
0.1
38640
|
L
H
0.1
146400
|
| PharmaCyte Biotech Inc |
|
8.3
|
0.8
|
L
 1.3%
H
0.7
0.8
|
L
 6.9%
H
0.7
0.8
|
L
 -2.5%
H
0.7
0.9
|
L
 -1.3%
H
0.6
1.0
|
L
 -26.7%
H
0.6
1.5
|
L
 -73.3%
H
0.6
3.0
|
L
 -96.1%
H
0.6
21.5
|
L
 -99.0%
H
0.6
253.4
|
| AIxCrypto Holdings Inc |
|
21.9
|
1.1
|
L
 2.9%
H
1.1
1.2
|
L
 -26.0%
H
1.0
1.5
|
L
 -15.6%
H
1.0
1.6
|
L
 -8.5%
H
1.0
1.7
|
L
 -69.5%
H
0.9
8.8
|
L
 -97.7%
H
0.1
63
|
L
 -99.9%
H
0.1
1560
|
L
 -100.0%
H
0.1
468750
|
| Revolution Medicines Inc |
|
38,709.6
|
182.1
|
L
 2.2%
H
174.3
183.4
|
L
 11.7%
H
162.2
184.4
|
L
 17.6%
H
141.4
184.4
|
L
 95.3%
H
91.5
184.4
|
L
 385.8%
H
34
184.4
|
L
 632.1%
H
15.5
184.4
|
L
 446.1%
H
14.1
184.4
|
L
H
14.1
184.4
|
| Upexi Inc |
|
62.7
|
0.8
|
L
 9.2%
H
0.8
0.8
|
L
 -8.8%
H
0.7
1.0
|
L
 -36.2%
H
0.7
1.3
|
L
 -22.4%
H
0.7
1.6
|
L
 -73.7%
H
0.5
10.6
|
L
 -98.3%
H
0.5
50
|
L
 -99.5%
H
0.5
187.2
|
L
H
0.5
187.4
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
1.3
|
0.3
|
L
 -3.9%
H
0.3
0.3
|
L
 -21.9%
H
0.3
0.3
|
L
 -47.9%
H
0.3
0.5
|
L
 -58.3%
H
0.3
1.1
|
L
 -89.9%
H
0.3
3.5
|
L
 -98.2%
H
0.3
46.9
|
L
 -99.9%
H
0.3
419
|
L
 -99.9%
H
0.3
6200
|
| FitLife Brands Inc |
|
104.1
|
11.1
|
L
 -7.1%
H
10.8
12.0
|
L
 -1.7%
H
10.5
12.8
|
L
 11.6%
H
9.5
12.8
|
L
 -19.9%
H
8.7
14.5
|
L
 -13.4%
H
8.7
21.0
|
L
 -33.1%
H
8.7
35.5
|
L
 -33.1%
H
8.7
35.5
|
L
 -33.1%
H
8.7
35.5
|
| Abivax (ADR) |
|
7,777.6
|
97.5
|
L
 5.6%
H
93.0
99.2
|
L
 -1.7%
H
74.8
103.8
|
L
 -22.9%
H
69.8
135.1
|
L
 -10.9%
H
69.8
135.1
|
L
 1257.9%
H
7.2
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| Synergy CHC Corp |
|
3.1
|
0.2
|
L
 5%
H
0.2
0.2
|
L
 -12.5%
H
0.2
0.2
|
L
 -19.2%
H
0.2
0.4
|
L
 -82.2%
H
0.2
1.3
|
L
 -91.6%
H
0.2
4
|
L
H
0.2
4.6
|
L
H
0.2
4.6
|
L
H
0.2
4.6
|
| iBio Inc |
|
83.0
|
1.7
|
L
 5.0%
H
1.6
1.7
|
L
 -1.2%
H
1.6
1.8
|
L
 -8.2%
H
1.5
2.1
|
L
 -4.0%
H
1.4
2.3
|
L
 135.2%
H
0.6
3.8
|
L
 108.8%
H
0.6
3.8
|
L
 108.8%
H
0.6
3.8
|
L
 108.8%
H
0.6
3.8
|